Investor Relations


Precigen Business and Pipeline Update Call
 Tuesday, November 12, 2019
 11:00am EST

Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients and a wholly owned subsidiary of Intrexon, hosted a conference call November 12th, 2019, at 11:00 AM ET to provide Precigen business and pipeline updates.  A replay of the webcast may be acccessed through Intrexon’s website in the Investors section at or Precigen’s website in the Presentations section at